Synopsis
0
JDMF
0
EU WC
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Topical
Solubilizers
Coating Systems & Additives
Thickeners and Stabilizers
Film Formers & Plasticizers
Co-Processed Excipients
Controlled & Modified Release
Granulation
Direct Compression
Surfactant & Foaming Agents
Fillers, Diluents & Binders
Emulsifying Agents
Taste Masking
API Stability Enhancers
Digital Content
DATA COMPILATION #PharmaFlow
Market Place
ABOUT THIS PAGE
43
PharmaCompass offers a list of Zinc Sulfate Heptahydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zinc Sulfate Heptahydrate manufacturer or Zinc Sulfate Heptahydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zinc Sulfate Heptahydrate manufacturer or Zinc Sulfate Heptahydrate supplier.
PharmaCompass also assists you with knowing the Zinc Sulfate Heptahydrate API Price utilized in the formulation of products. Zinc Sulfate Heptahydrate API Price is not always fixed or binding as the Zinc Sulfate Heptahydrate Price is obtained through a variety of data sources. The Zinc Sulfate Heptahydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ZnSO4.7H2O manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ZnSO4.7H2O, including repackagers and relabelers. The FDA regulates ZnSO4.7H2O manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ZnSO4.7H2O API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of ZnSO4.7H2O manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A ZnSO4.7H2O supplier is an individual or a company that provides ZnSO4.7H2O active pharmaceutical ingredient (API) or ZnSO4.7H2O finished formulations upon request. The ZnSO4.7H2O suppliers may include ZnSO4.7H2O API manufacturers, exporters, distributors and traders.
click here to find a list of ZnSO4.7H2O suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A ZnSO4.7H2O DMF (Drug Master File) is a document detailing the whole manufacturing process of ZnSO4.7H2O active pharmaceutical ingredient (API) in detail. Different forms of ZnSO4.7H2O DMFs exist exist since differing nations have different regulations, such as ZnSO4.7H2O USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A ZnSO4.7H2O DMF submitted to regulatory agencies in the US is known as a USDMF. ZnSO4.7H2O USDMF includes data on ZnSO4.7H2O's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The ZnSO4.7H2O USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of ZnSO4.7H2O suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a ZnSO4.7H2O Drug Master File in Korea (ZnSO4.7H2O KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of ZnSO4.7H2O. The MFDS reviews the ZnSO4.7H2O KDMF as part of the drug registration process and uses the information provided in the ZnSO4.7H2O KDMF to evaluate the safety and efficacy of the drug.
After submitting a ZnSO4.7H2O KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their ZnSO4.7H2O API can apply through the Korea Drug Master File (KDMF).
click here to find a list of ZnSO4.7H2O suppliers with KDMF on PharmaCompass.
A ZnSO4.7H2O CEP of the European Pharmacopoeia monograph is often referred to as a ZnSO4.7H2O Certificate of Suitability (COS). The purpose of a ZnSO4.7H2O CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of ZnSO4.7H2O EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of ZnSO4.7H2O to their clients by showing that a ZnSO4.7H2O CEP has been issued for it. The manufacturer submits a ZnSO4.7H2O CEP (COS) as part of the market authorization procedure, and it takes on the role of a ZnSO4.7H2O CEP holder for the record. Additionally, the data presented in the ZnSO4.7H2O CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the ZnSO4.7H2O DMF.
A ZnSO4.7H2O CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. ZnSO4.7H2O CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of ZnSO4.7H2O suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing ZnSO4.7H2O as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for ZnSO4.7H2O API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture ZnSO4.7H2O as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain ZnSO4.7H2O and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a ZnSO4.7H2O NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of ZnSO4.7H2O suppliers with NDC on PharmaCompass.
ZnSO4.7H2O Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ZnSO4.7H2O GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ZnSO4.7H2O GMP manufacturer or ZnSO4.7H2O GMP API supplier for your needs.
A ZnSO4.7H2O CoA (Certificate of Analysis) is a formal document that attests to ZnSO4.7H2O's compliance with ZnSO4.7H2O specifications and serves as a tool for batch-level quality control.
ZnSO4.7H2O CoA mostly includes findings from lab analyses of a specific batch. For each ZnSO4.7H2O CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ZnSO4.7H2O may be tested according to a variety of international standards, such as European Pharmacopoeia (ZnSO4.7H2O EP), ZnSO4.7H2O JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ZnSO4.7H2O USP).
